Characterization of DNA damage repair (DDR) alterations and the tumor immune microenvironment (TIME) in advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Sankar, Kamya
Mercer, Jacob
Jaeger, Ellen B.
Godden, Jen
Berkman, Jonathan David
Williams, Edward
Thompson, Michael A.
Patel, Shetal Arvind
Reckamp, Karen L.
Weinberg, Frank
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA USA
[2] Tempus AI, Chicago, IL USA
[3] Tempus Labs Inc, Chicago, IL USA
[4] VCU Massey Canc Ctr, Richmond, VA USA
[5] Univ N Carolina, Chapel Hill, NC USA
[6] Univ Illinois, Dept Hematol Oncol, Coll Med, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8603
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [31] Spatial heterogeneity of infiltrating immune cells in the tumor microenvironment of non-small cell lung cancer
    Liu, Xinyue
    Kong, Yan
    Qian, Youwen
    Guo, Haoyue
    Zhao, Lishu
    Wang, Hao
    Xu, Kandi
    Ye, Li
    Liu, Yujin
    Lu, Hui
    He, Yayi
    TRANSLATIONAL ONCOLOGY, 2024, 50
  • [32] Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer
    Fengying Wu
    Jue Fan
    Yayi He
    Anwen Xiong
    Jia Yu
    Yixin Li
    Yan Zhang
    Wencheng Zhao
    Fei Zhou
    Wei Li
    Jie Zhang
    Xiaosheng Zhang
    Meng Qiao
    Guanghui Gao
    Shanhao Chen
    Xiaoxia Chen
    Xuefei Li
    Likun Hou
    Chunyan Wu
    Chunxia Su
    Shengxiang Ren
    Margarete Odenthal
    Reinhard Buettner
    Nan Fang
    Caicun Zhou
    Nature Communications, 12
  • [33] STATUS OF IMMUNE THERAPY IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Parums, D. V.
    DRUGS OF THE FUTURE, 2014, 39 (07) : 469 - 477
  • [34] Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer
    Wu, Fengying
    Fan, Jue
    He, Yayi
    Xiong, Anwen
    Yu, Jia
    Li, Yixin
    Zhang, Yan
    Zhao, Wencheng
    Zhou, Fei
    Li, Wei
    Zhang, Jie
    Zhang, Xiaosheng
    Qiao, Meng
    Gao, Guanghui
    Chen, Shanhao
    Chen, Xiaoxia
    Li, Xuefei
    Hou, Likun
    Wu, Chunyan
    Su, Chunxia
    Ren, Shengxiang
    Odenthal, Margarete
    Buettner, Reinhard
    Fang, Nan
    Zhou, Caicun
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [35] IMPROVING TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Reck, M.
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4038 - 4038
  • [36] Cetuximab in advanced non-small cell lung cancer (NSCLC): the showdown?
    Sgambato, Assunta
    Casaluce, Francesca
    Maione, Paolo
    Rossi, Antonio
    Ciardiello, Fortunato
    Gridelli, Cesare
    JOURNAL OF THORACIC DISEASE, 2014, 6 (06) : 578 - 580
  • [37] ERLOTINIB IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) TREATMENT
    Goncalves, Ivone M.
    Monteiro, Regina
    Neves, Sofia
    Conde, Sara
    Campainha, Sergio
    Parente, Barbara
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1298 - S1298
  • [38] Gemcitabine and cisplatin for advanced non-small cell lung cancer (NSCLC)
    Casal, J
    Grande, C
    Caeiro, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1083 - 1083
  • [39] The Immune Microenvironment in Brain Metastases of Non-Small Cell Lung Cancer
    Luo, Lumeng
    Liu, Peiyi
    Zhao, Kuaile
    Zhao, Weixin
    Zhang, Xiaofei
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [40] m6A regulators featured by tumor immune microenvironment landscapes and correlated with immunotherapy in non-small cell lung cancer (NSCLC)
    Yuan, Baowen
    Qin, Hao
    Zhang, Jingyao
    Zhang, Min
    Yang, Yunkai
    Teng, Xu
    Yu, Hefen
    Huang, Wei
    Wang, Yan
    FRONTIERS IN ONCOLOGY, 2022, 12
12345